Zandy Anna J, Bassnett Steven
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):293-302. doi: 10.1167/iovs.06-0656.
To remove light-scattering structures from the visual axis, all intracellular organelles are eliminated from cells in the center of the developing ocular lens. Organelle degradation is accompanied by an increase in VEIDase (caspase-6-like) activity, but data from caspase-null mice suggest that the lens VEIDase is not caspase-6. The goal of the present work was to identify the lens VEIDase and determine whether it plays a role in organelle breakdown.
The approximate molecular mass of the lens VEIDase was determined by size-exclusion chromatography. Three proteasome inhibitors (NLVS, MG132, and clasto-lactacystin beta-lactone) were tested for their ability to inhibit lens VEIDase activity. Lens lysates were immunodepleted of proteasomes using an antibody against the 20S proteasome. To inhibit the ubiquitin-proteasome pathway (UPP) in vivo, lactacystin was injected into the vitreous humor of the developing chicken eye. The effect of lactacystin on mitochondrial degradation was assessed by examining the disappearance of succinate-ubiquinone oxidoreductase, an integral protein of the inner mitochondrial membrane.
The lens VEIDase eluted at approximately 700 kDa from a size-exclusion column and was inhibited by the proteasome inhibitors NLVS, MG132, and clasto-lactacystin beta-lactone. In vivo, the trypsin-like activity of the proteasome was reduced by 60% to 70% after lactacystin injection. Proteasome inhibition was associated with the accumulation of ubiquitinated proteins and reversible opacification of the lens cortex. In lactacystin-injected eyes, the programmed degradation of succinate-ubiquinone oxidoreductase was inhibited in the central lens fiber cells.
These data suggest that lens VEIDase activity is attributable to the proteasome and that the UPP may function in the removal of organelle components during lens fiber cell differentiation.
为了清除视轴上的光散射结构,发育中的晶状体中央细胞内的所有细胞器都被清除。细胞器降解伴随着VEID酶(类半胱天冬酶-6)活性的增加,但来自半胱天冬酶基因敲除小鼠的数据表明晶状体VEID酶不是半胱天冬酶-6。本研究的目的是鉴定晶状体VEID酶,并确定其是否在细胞器分解中起作用。
通过尺寸排阻色谱法测定晶状体VEID酶的近似分子量。测试了三种蛋白酶体抑制剂(NLVS、MG132和clasto-乳胞素β-内酯)抑制晶状体VEID酶活性的能力。使用抗20S蛋白酶体的抗体对晶状体裂解物进行蛋白酶体免疫去除。为了在体内抑制泛素-蛋白酶体途径(UPP),将乳胞素注入发育中的鸡眼玻璃体内。通过检查线粒体内膜整合蛋白琥珀酸-泛醌氧化还原酶的消失来评估乳胞素对线粒体降解的影响。
晶状体VEID酶从尺寸排阻柱上以约700 kDa的分子量洗脱,并被蛋白酶体抑制剂NLVS、MG132和clasto-乳胞素β-内酯抑制。在体内,注射乳胞素后蛋白酶体的胰蛋白酶样活性降低了60%至70%。蛋白酶体抑制与泛素化蛋白的积累和晶状体皮质的可逆性混浊有关。在注射乳胞素的眼中,晶状体中央纤维细胞中线粒体琥珀酸-泛醌氧化还原酶的程序性降解受到抑制。
这些数据表明晶状体VEID酶活性归因于蛋白酶体,并且UPP可能在晶状体纤维细胞分化过程中参与细胞器成分的清除。